Friday, 15 April 2016

15th April

Control Phase - Implement the solution and control plan:

The Control stage began in early April. In the initial stage of the project we noted the following:

Observation – High level of kinks observed in the Generic area with a negative trend in November.
Initial Action – Measles chart put online to establish where kinks were occurring on the catheter. (Laser marking and Coat Prep)
Outcome – Issues observed as follows:
- Charts were being removed/not filled in across all shifts.
- Insufficient information obtained.

Action taken by the Team to combat this:
Updated measles charts were introduced to include stations.



Define Location of Kink on Catheter


Station
Signature/Date
Kinks noticed pre station (Qty)
Kinks noticed post station (Qty)
Hub
Proximal
Mid
Distal
Reflow







Moulding







Print hubs







Coat prep







Coating







Tip form 1







Tip form 2







Tip form 3







Pre-shape










Outcome – Issues observed as follows
Charts were filled in regardless if kinks were noticed or not.
Immediate impact as kinks significantly reduced.

The next action is to maintain and control the reduction in kinks for the foreseeable future.
Potential Options:
v  Keep the measles charts as a permanent fix?
v  LST review kink trend daily/weekly/monthly?
v  Kink champion from each shift onus on PB’s driven by PB’s on line
v  Implementation of updated Standard Audit to support long term sustainability?
v  Weekly Team Meetings

Weekly Team Meetings:
Team meetings are conducted by myself or the Production Team Lead. Going forward the Manufacturing Engineer/Technician for the line will present on the issues from the daily meetings to the Product Builder team. Historically when we have highlighted issues of concern to the PB group we have found that they respond very quickly to help solve issues. However once the initial reaction has worn off we tend to see the same issues come back again in order to combat this we believe that a weekly update will keep the focus for this group and improve the yield and output of the Generic area.

Potential Savings:

v  €96,216 per annum in scrap.
v  2,088 units, based on lot sizes of 54 this would mean 39 extra lots per annum.

Scrap CostNov-15Dec-15Jan-16Feb-16Mar-16
Catheter x112606854234527852207
Catheter y19095438329016381873
Total1316912292563544234080


From the graph above you can see the improvement from the solutions put in place to tackle the kink issue we were having on Cath X and Cath Y. In November 2015 we had a scrap cost of €13,169 there is now a significant drop in scrap cost which is evident in March of 2016 (scrap cost of €4,080).

Friday, 1 April 2016

01st April 2016

Improve Phase - Develop improvement solutions for the critical X's.

Following on from the Analyse phase and proposed solutions/actions generated from the brainstorming, fishbone diagram and cause and effect analysis the team decided to introduce inspection at Coat Prep for moulding string: Post our moulding process and also during the coat prep process, moulding machine drool string can attach to the distal end of the catheters resulting in a high potential for kinks during seperation of units. To reduce drool factor an extraction system will be added to the Moulding room.


We then drew up our assessment criteria and the Team developed a consensus using multi voting in which team members apportioned 100 points across the assessment criteria.
"Will not impact Quality" and "Will solve the Problem" were deemed most important.

Weighting of assessment criteria



As well as introducing inspection to coat prep and reducing string from the moulding machine introduction of a tip trimming fixture for Tip Form and optimising the position of the tree which holds the catheters during moulding were our top solutions.
As a Team we assessed each proposed solution by scoring each item with a rating of 1 - 10 (10 being best) and summing up the combined weighted score we then drew up a prioritisation matrix.


Tip Trimming Fixture:

We are now ready to move onto the final stage the control phase.